Aldeyra Therapeutics, Inc. · NASDAQ:ALDX
Aldeyra Therapeutics, Inc. shareholders
As of Jun 30, 2026, 103 institutions reported holding Aldeyra Therapeutics, Inc., 60.9% of its shares. Largest: Knoll Capital Management, LLC, AQR Capital Management LLC and Vanguard. New holders, exits, insiders and big stakes, each with its filing.
| Holder | Shares | % of Aldeyra Therapeutics, Inc. | Change | Filed |
|---|---|---|---|---|
| Knoll Capital Management, LLC | 5.48M | 9.1% | no change | Aug 14, 2026 |
| AQR Capital Management LLC | 3.75M | 6.2% | +922K | Aug 14, 2026 |
| Vanguard | 3.47M | 5.8% | −55,240 | Aug 13, 2026 |
| Kingdon Capital Management, L.L.C. | 2.65M | 4.4% | +500K | Aug 14, 2026 |
| D. E. Shaw & Co., Inc. | 1.94M | 3.2% | +536K | Aug 14, 2026 |
| Marshall Wace, LLP | 1.51M | 2.5% | +1.38M | Aug 13, 2026 |
| 683 Capital Management, LLC | 1.45M | 2.4% | −50,000 | Aug 14, 2026 |
| Jane Street | 1.38M | 2.3% | +406K | Aug 14, 2026 |
| BlackRock | 1.26M | 2.1% | −2.51M | Aug 7, 2026 |
| Qube Research & Technologies Ltd | 1.13M | 1.9% | +1.04M | Aug 14, 2026 |